vs
Side-by-side financial comparison of GREENE COUNTY BANCORP INC (GCBC) and ImmunityBio, Inc. (IBRX). Click either name above to swap in a different company.
ImmunityBio, Inc. is the larger business by last-quarter revenue ($38.3M vs $22.2M, roughly 1.7× GREENE COUNTY BANCORP INC). GREENE COUNTY BANCORP INC runs the higher net margin — 46.3% vs -161.8%, a 208.1% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs 23.8%). GREENE COUNTY BANCORP INC produced more free cash flow last quarter ($6.2M vs $-71.3M).
Bank of Greene County is an American federally-chartered savings bank headquartered in Catskill, NY. The bank's branches are located in the Upstate New York counties of Greene, Columbia, Albany, Ulster, and Rensselaer.
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
GCBC vs IBRX — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $22.2M | $38.3M |
| Net Profit | $10.3M | $-61.9M |
| Gross Margin | — | 99.0% |
| Operating Margin | 52.0% | -169.0% |
| Net Margin | 46.3% | -161.8% |
| Revenue YoY | 23.8% | 407.0% |
| Net Profit YoY | 37.4% | -4.7% |
| EPS (diluted) | $0.60 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $22.2M | $38.3M | ||
| Q3 25 | $21.5M | $32.1M | ||
| Q2 25 | $20.5M | $26.4M | ||
| Q1 25 | $20.1M | $16.5M | ||
| Q4 24 | $17.9M | $7.6M | ||
| Q3 24 | $16.9M | $6.1M | ||
| Q2 24 | $16.6M | — | ||
| Q1 24 | $15.7M | — |
| Q4 25 | $10.3M | $-61.9M | ||
| Q3 25 | $8.9M | $-67.3M | ||
| Q2 25 | $9.3M | $-92.6M | ||
| Q1 25 | $8.1M | $-129.6M | ||
| Q4 24 | $7.5M | $-59.2M | ||
| Q3 24 | $6.3M | $-85.7M | ||
| Q2 24 | $6.7M | — | ||
| Q1 24 | $5.9M | — |
| Q4 25 | — | 99.0% | ||
| Q3 25 | — | 99.4% | ||
| Q2 25 | — | 99.5% | ||
| Q1 25 | — | 99.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 52.0% | -169.0% | ||
| Q3 25 | 47.4% | -173.5% | ||
| Q2 25 | 53.5% | -269.8% | ||
| Q1 25 | 44.6% | -390.1% | ||
| Q4 24 | 45.0% | -919.0% | ||
| Q3 24 | 39.6% | -1314.3% | ||
| Q2 24 | 41.2% | — | ||
| Q1 24 | 39.4% | — |
| Q4 25 | 46.3% | -161.8% | ||
| Q3 25 | 41.2% | -209.8% | ||
| Q2 25 | 45.6% | -350.3% | ||
| Q1 25 | 40.1% | -784.9% | ||
| Q4 24 | 41.7% | -783.4% | ||
| Q3 24 | 37.1% | -1404.0% | ||
| Q2 24 | 40.6% | — | ||
| Q1 24 | 37.3% | — |
| Q4 25 | $0.60 | $-0.06 | ||
| Q3 25 | $0.52 | $-0.07 | ||
| Q2 25 | $0.55 | $-0.10 | ||
| Q1 25 | $0.47 | $-0.15 | ||
| Q4 24 | $0.44 | $-0.08 | ||
| Q3 24 | $0.37 | $-0.14 | ||
| Q2 24 | $0.39 | — | ||
| Q1 24 | $0.34 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $242.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $258.3M | $-500.5M |
| Total Assets | $3.1B | $501.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $242.8M | ||
| Q3 25 | — | $257.8M | ||
| Q2 25 | — | $153.7M | ||
| Q1 25 | $155.5M | $61.6M | ||
| Q4 24 | $166.4M | $149.8M | ||
| Q3 24 | — | $130.4M | ||
| Q2 24 | $190.4M | — | ||
| Q1 24 | — | — |
| Q4 25 | $258.3M | $-500.5M | ||
| Q3 25 | $248.2M | $-524.3M | ||
| Q2 25 | $238.8M | $-570.7M | ||
| Q1 25 | $229.0M | $-591.4M | ||
| Q4 24 | $218.4M | $-489.1M | ||
| Q3 24 | $216.3M | $-745.1M | ||
| Q2 24 | $206.0M | — | ||
| Q1 24 | $199.2M | — |
| Q4 25 | $3.1B | $501.9M | ||
| Q3 25 | $3.1B | $519.0M | ||
| Q2 25 | $3.0B | $402.1M | ||
| Q1 25 | $3.0B | $303.8M | ||
| Q4 24 | $3.0B | $382.9M | ||
| Q3 24 | $2.9B | $364.6M | ||
| Q2 24 | $2.8B | — | ||
| Q1 24 | $2.9B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $6.4M | $-70.4M |
| Free Cash FlowOCF − Capex | $6.2M | $-71.3M |
| FCF MarginFCF / Revenue | 28.0% | -186.2% |
| Capex IntensityCapex / Revenue | 0.9% | 2.4% |
| Cash ConversionOCF / Net Profit | 0.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $47.3M | $-308.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.4M | $-70.4M | ||
| Q3 25 | $7.0M | $-68.9M | ||
| Q2 25 | $28.0M | $-79.7M | ||
| Q1 25 | $7.3M | $-85.9M | ||
| Q4 24 | $5.3M | $-85.1M | ||
| Q3 24 | $2.1M | $-98.8M | ||
| Q2 24 | $24.9M | — | ||
| Q1 24 | $5.6M | — |
| Q4 25 | $6.2M | $-71.3M | ||
| Q3 25 | $6.5M | $-69.6M | ||
| Q2 25 | $27.3M | $-80.8M | ||
| Q1 25 | $7.3M | $-87.0M | ||
| Q4 24 | $5.1M | $-87.3M | ||
| Q3 24 | $2.0M | $-101.6M | ||
| Q2 24 | $23.4M | — | ||
| Q1 24 | $4.9M | — |
| Q4 25 | 28.0% | -186.2% | ||
| Q3 25 | 30.4% | -217.2% | ||
| Q2 25 | 133.3% | -305.9% | ||
| Q1 25 | 36.1% | -526.9% | ||
| Q4 24 | 28.6% | -1155.4% | ||
| Q3 24 | 11.8% | -1663.2% | ||
| Q2 24 | 141.2% | — | ||
| Q1 24 | 31.3% | — |
| Q4 25 | 0.9% | 2.4% | ||
| Q3 25 | 1.9% | 2.3% | ||
| Q2 25 | 3.4% | 4.1% | ||
| Q1 25 | 0.3% | 6.8% | ||
| Q4 24 | 1.0% | 28.0% | ||
| Q3 24 | 0.9% | 45.7% | ||
| Q2 24 | 9.1% | — | ||
| Q1 24 | 4.2% | — |
| Q4 25 | 0.62× | — | ||
| Q3 25 | 0.78× | — | ||
| Q2 25 | 3.00× | — | ||
| Q1 25 | 0.91× | — | ||
| Q4 24 | 0.71× | — | ||
| Q3 24 | 0.34× | — | ||
| Q2 24 | 3.70× | — | ||
| Q1 24 | 0.95× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
